US 9833479
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
granted A61KA61K2035/124A61K35/12
Quick answer
US patent 9833479 (Gene correction of SCID-related genes in hematopoietic stem and progenitor cells) held by Sangamo Therapeutics, Inc. expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2035/124, A61K35/12, A61K35/28, A61K35/545